FDA Approves Additional Dosing Option of Durvalumab for ... | 合法藥品大搜索

Note: Cycle is 28 days · Durvalumab 1500 mg IV q4Weeks (if patient's body weight <30kg, dose at 10 mg/kg q2Weeks until weight >30 kg) · Continue until disease ... Read More

IMFINZI® (durvalumab) is supplied as single-use vials that contain either 120 mg/​2.4 mL or 500 mg/10 mL ... NSCLC=non-small cell lung cancer; Q2W=once every​ ... Read More

In general, if IMFINZI requires interruption or discontinuation, administer systemic corticosteroid therapy (1 mg to 2 mg/kg/day prednisone or equivalent) until ... Read More

2020年12月16日 — The FDA recommended that durvalumab be administered prior to chemotherapy at 1,500 mg every 3 weeks and then after the four cycles of ... Read More

2020年11月20日 — The FDA recommended that durvalumab be administered prior to chemotherapy at 1500 mg every 3 weeks and then after the 4 cycles of ... Read More

2020年11月30日 — Usual Adult Dose for Small Cell Lung Cancer · 30 kg or less: 20 mg/kg IV every 3 weeks (21 days) for 4 cycles, followed by 20 mg/kg every 4 ... Read More

The PK of durvalumab was studied in 2903 patients with solid tumours with doses ranging from 0.1 to 20 mg/kg administered intravenously once every two, three ... Read More

chemotherapy, refer to the Prescribing Information for etoposide and carboplatin or cisplatin for dosing information. 2.2 Dosage Modifications for Adverse ... Read More

2020年11月20日 — The FDA approved a 1500 mg fixed dose of durvalumab (Imfinzi) administered every 4 weeks for the treatment of unresectable stage III ... Read More